Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
FMS Fresenius Medical Care
- 25.070
- +0.610+2.49%
Close Apr 28 16:00 ET
- 25.090
- +0.020+0.08%
Pre 07:15 ET
14.71BMarket Cap23.99P/E (TTM)
25.070High24.840Low232.69KVolume24.840Open24.460Pre Close5.80MTurnover0.06%Turnover Ratio23.99P/E (Static)586.83MShares25.96052wk High0.88P/B10.50BFloat Cap17.93052wk Low0.62Dividend TTM418.93MShs Float51.650Historical High2.45%Div YieldTTM0.94%Amplitude0.515Historical Low24.941Avg Price1Lot Size
Fresenius Medical Care Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.23%2.39B | -56.11%442M | 21.29%2.63B | 34.09%1.01B | -10.00%142.84M | -12.94%2.17B | ||||
| Net income from continuing operations | 1.15%740.87M | -53.65%118.87M | 79.59%264M | 23.59%241M | -18.10%732.46M | --256.46M | -48.04%147M | -5.34%195M | -36.80%133.85M | -26.64%894.33M |
| Operating gains losses | -9.17%-147.04M | ---- | ---- | ---- | 18.78%-134.69M | ---- | ---- | ---- | -278.21%-53.41M | -244.85%-165.83M |
| Depreciation and amortization | -0.55%1.74B | ---- | ---- | -10.83%387M | -4.70%1.75B | ---- | ---- | 2.84%434M | 4.50%437.81M | 13.22%1.84B |
| Deferred tax | 40.51%-72.67M | ---- | ---- | ---- | -194.54%-122.15M | ---- | ---- | ---- | -140.70%-22.37M | -161.66%-41.47M |
| Other non cash items | -0.28%335.47M | 45.65%-596.53M | 17.62%721M | ---- | 15.03%336.42M | ---1.1B | 701.46%613M | ---- | 19.50%82.57M | 4.30%292.48M |
| Change In working capital | -20.84%444.31M | ---- | ---- | -149.21%-186M | 538.27%561.28M | ---- | ---- | 207.32%378M | 17.18%-337.67M | -30.99%-128.07M |
| -Change in receivables | 51.61%-73.48M | 1,082.15%155.52M | 645.88%464M | -107.06%-23M | -225.27%-151.84M | --13.16M | -324.26%-85M | 84.18%326M | -42.46%-356.85M | 71.40%-46.68M |
| -Change in inventory | 921.13%107.9M | 123.74%95.9M | 23.64%68M | 31.82%-15M | 93.57%-13.14M | --42.86M | 208.42%55M | 60.71%-22M | -42.44%-88.39M | -320.99%-204.31M |
| -Change in payables and accrued expense | 9.87%637.86M | ---- | ---- | ---- | 1,966.22%580.56M | ---- | ---- | ---- | 175.63%115.72M | 38.08%-31.11M |
| -Change in other current assets | -256.47%-227.97M | ---- | ---- | ---- | -5.41%145.7M | ---- | ---- | ---- | -114.08%-8.15M | -6.19%154.03M |
| -Change in other working capital | ---- | ---- | ---- | -300.00%-148M | ---- | ---- | ---- | 3,600.00%74M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.23%2.39B | 15.77%832.14M | 29.61%985M | -56.11%442M | 21.29%2.63B | --718.8M | 15.57%760M | 34.09%1.01B | -10.00%142.84M | -12.94%2.17B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 84.39%-84.94M | 1.29%-306M | 25.93%-544.23M | 8.28%-310M | 22.73%-163.28M | 38.58%-734.73M | ||||
| Capital expenditure reported | ---- | ---- | -26.87%-170M | 1.29%-153M | ---- | ---- | ---134M | 8.28%-155M | ---- | ---- |
| Net PPE purchase and sale | -2.51%-685.26M | ---- | ---- | 1.29%-153M | 2.81%-668.46M | ---- | ---- | 8.28%-155M | 12.11%-140.49M | 17.13%-687.78M |
| Net business purchase and sale | 342.84%606.68M | ---- | ---- | ---- | 13,226.75%137M | ---- | ---- | ---- | 136.25%8.07M | 100.27%1.03M |
| Net investment purchase and sale | 50.13%-6.37M | ---- | ---- | ---- | 73.38%-12.77M | ---- | ---- | ---- | -5.69%-30.86M | -410.79%-47.97M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 84.39%-84.94M | ---- | ---- | 1.29%-306M | 25.93%-544.23M | ---- | ---- | 8.28%-310M | 22.73%-163.28M | 38.58%-734.73M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -38.24%-2.57B | -14.91%-1.86B | 100.76%2.01M | -57.89%-1.62B | ||||||
| Net issuance payments of debt | -60.12%-1.91B | ---- | ---- | ---- | -6.42%-1.19B | ---- | ---- | ---- | 79.66%-148.84M | -211.51%-1.12B |
| Cash dividends paid | -6.25%-349.16M | ---- | ---- | ---- | 16.92%-328.62M | ---- | ---- | ---- | ---- | -0.79%-395.56M |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 209.52%20.15M |
| Net other financing activities | 7.39%-314.99M | ---- | ---- | ---- | -174.40%-340.11M | ---- | ---- | ---- | -67.50%150.85M | 55.66%-123.95M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -38.24%-2.57B | ---- | ---- | ---- | -14.91%-1.86B | ---- | ---- | ---- | 100.76%2.01M | -57.89%-1.62B |
| Net cash flow | ||||||||||
| Beginning cash position | 12.05%1.43B | ---- | ---- | ---- | -14.03%1.27B | ---- | ---- | ---- | -14.03%1.27B | 37.00%1.48B |
| Current changes in cash | -218.60%-268.1M | ---- | ---- | ---- | 222.38%226.05M | ---- | ---- | ---- | 94.23%-18.43M | -168.69%-184.71M |
| Effect of exchange rate changes | 136.08%26.2M | ---- | ---- | ---- | -213.47%-72.61M | ---- | ---- | ---- | -387.47%-31.47M | -117.65%-23.16M |
| End cash Position | -16.95%1.19B | ---- | ---- | ---- | 12.05%1.43B | ---- | ---- | ---- | 4.31%1.22B | -14.03%1.27B |
| Free cash flow | -13.24%1.69B | 16.21%1.04B | 31.90%645M | -81.35%130M | 34.70%1.94B | --898.21M | -1.66%489M | 70.00%697M | 120.77%704K | -11.73%1.44B |
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now